MIRA INFORM REPORT
|
Report Date : |
09.03.2012 |
IDENTIFICATION DETAILS
|
Name : |
P.T. AIRINDO SENTRA MEDIKA |
|
|
|
|
Registered Office : |
Jalan Teuku Nyak Arif No. 10, Jakarta Selatan, 12220 |
|
|
|
|
Country : |
Indonesia |
|
|
|
|
Date of Incorporation : |
23.02.1983 |
|
|
|
|
Com. Reg. No.: |
No. AHU-AH.01.10-40131 |
|
|
|
|
Legal Form : |
Limited
Liability Company |
|
|
|
|
Line of Business : |
Trading, Import, Distribution and Supply of Medical Equipment and Hospital Engineering |
|
|
|
|
No. of Employees
: |
17 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 539,400 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Indonesia |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
P.T. AIRINDO SENTRA MEDIKA
Head Office
Jalan Teuku Nyak Arif No. 10
Jakarta Selatan, 12220
Indonesia
Phones -
(62-21) 72800673-77
Fax - (62-21) 72783622
E-mail - info@airindo.com
Website - http://www.airindo.com
Building Area - 2 storey
Office Space - 120 sq. meters
Region - Commercial
Status - Rent
23 February 1983
P.T. (Perseroan
Terbatas) or Limited Liability Company
The Ministry of
Law and Human Rights
- No. C2-5904.HT.01.04.TH.92
Dated 20 July 1992
- No. AHU-56678.AH.01.02.TH.2011
Dated 21 November 2011
- No. AHU-AH.01.10-40131
Dated 9 December 2011
Private National Company
The Department of
Finance
NPWP No.
01.909.548.8-013.000
P.T. MULTI
MEDINDO MADYATAMA (Trading and Distribution of Scientific and Laboratory
Instruments)
Capital
Structure :
Authorized
Capital : Rp.
11,000,000,000.-
Issued Capital : Rp.
11,000,000,000.-
Paid up Capital : Rp.
11,000,000,000.-
Shareholders/Owners
:
a. Mr. Hudiono
Prasetyo -
Rp. 5,500,000,000.-
Address : Jl. Surya Nirmala Q/21,
RT. 007 RW. 005
Kel. Kedoya Utara, Kec. Kebon Jeruk
Jakarta
Barat
Indonesia
b. Mrs. Ratna
Wijayanti Kusumawardani -
Rp. 3,850,000,000.-
Address : Jl. Surya Nirmala
Q/21, RT. 007 RW. 005
Kel. Kedoya Utara, Kec. Kebon Jeruk
Jakarta
Barat
Indonesia
c. Mr. Marco Dewanto Prasetya - Rp. 1,650,000,000.-
Address : Jl. Surya Nirmala Q/21,
RT. 007 RW. 005
Kel. Kedoya Utara, Kec. Kebon Jeruk
Jakarta
Barat
Indonesia
Lines of
Business :
Trading, Import,
Distribution and Supply of Medical Equipment and Hospital Engineering
Production
Capacity :
None
Total
Investment :
None
Started
Operation :
1984
Brand Name :
Airindo Sentra
Medika
Technical
Assistance :
None
Number of
Employee :
17 persons
Marketing Area
:
Local - 100%
Main Customer
:
Hospitals and
Medical Check Up
Market
Situation :
Very Competitive
Main Competitors
:
a. C.V. BETA
MEDICAL
b. P.T. DAMARUS
PANEN UTAMA
c. P.T.
INTEGRASTA NUSANTARA
d. P.T. MULTI
SARANA UTAMA
e. Etc.
Business Trend
:
Growing
Bankers :
a. P.T. Bank
MANDIRI Tbk
Jalan
Teuku Nyak Arief No. 10
Jakarta
Selatan
Indonesia
b. P.T. Bank CIMB NIAGA Tbk
Jalan Paletehan No. 2
Jakarta
Selatan
Indonesia
Auditor :
Internal Auditor
Litigation :
No litigation
record in our database
Annual Sales
(estimated) :
2009 – Rp. 37.8 billion
2010 – Rp. 38.5
billion
2011 – Rp. 41.0
billion
Net Profit
(estimated) :
2009 – Rp. 2.3
billion
2010 – Rp. 2.5
billion
2011 – Rp. 2.8
billion
Payment Manner
:
Average
Financial
Comments :
Satisfactory
Board of Management :
President Director - Mr. Hudiono Prasetyo
Director -
Mr. Marco Dewanto Prasetya
Board of Commissioners :
President Commissioner -
Mrs. Ratna Wijayanti Kusumawarddani
Commissioner -
Mr. Johny Karamoy
Signatories :
President Director (Mr.
Hudiono Prasetyo) or the Director (Mr. Marco Dewanto Prasetya) which must be
approved by Board of Commissioner
Management Capability :
Good
Business Morality :
Good
Credit Risk :
Average
Credit Recommendation :
Credit should be proceeded with monitor
Proposed
Credit Limit :
Small amount –
periodical review
Maximum Credit Limit :
US$ 539,400 on 90
days D/A
P.T. AIRINDO SENTRA MEDIKA (formerly P.T. AIRINDO SENTRA DINAMIKA) abbreviated ASM was established in Jakarta on 23 February 1983 with an authorized capital of Rp. 25,000,000 issued capital of Rp. 5,000,000 wholly paid-up. The founding shareholders originally were Mr. Imron Jasin SE., Mr. Gusti Utomo and Mrs. Ir. Magdalena Rachman Azzan Jasin wholly indigenous businessmen. Its articles of association had been subsequently been changed for a couple of times. In December 1989, the authorized capital was increased to Rp. 500,000,000 issued capital to Rp. 100,000,000 wholly paid-up. On the same occasion, Mr. Timotius Dharmawan Harsono and Mrs. Minni Suharti Aminah Adjie, SE joined the company as the new shareholders. Later in 1997, Mrs. Minni Suharti Aminah Adjie SE., Mr. Imron Jasin and Mr. Gusti Utomo pulled-out as the shareholders and their whole shares were taken over by Mr. Hudiono Prasetyo with his wife Mrs. Ratna Wijayanti Kusumawardani and son namely Mr. Marco Dewanto Prassetya as new shareholders. Then in October 2011 the authorized capital was raised to Rp. 11,000,000,000 wholly issued and paid up. With this development the composition of its shareholders has been changed to become Mr. Hudiono Prasetyo (50%) his wife Mrs. Ratna Wijayanti Kusumawardani (35%) and son Mr. Marco Dewanto Prasetya (15%). The deed of amendment was approved by the Ministry of Law and Human Rights in its decision letter No. AHU-56678.AH.01.02.TH.2011 dated November 21, 2011. The latest according to the latest revision of notary documents of Mrs. Rohana Frieta, SH., a public notary in Jakarta in November 2011, Mr. Johny Karamoy trusted and appointed as Commissioner. The latest revision of notary documents was approved by the Ministry of Law and Human Rights in its decision letter No. AHU-AH.01.10-40131 dated December 9, 2011.
P.T. ASM started with operation in 1983 in trading, import, distribution and supply of medical equipment and hospital engineering. Originally P.T. ASM to our inquiry disclosed the company was appointed as a distributor for FICKER Medical equipments of the USA. The company provides a wide range of products and services that help hospitals and health institutions with the most challenging, life-timing medical problems. Medical equipment such as diagnostic, Critical Care (intensive care/coronary care units, patient monitoring, ICU ventilators, defibrillators, NIBP Monitors, etc), Operating Room (patient monitoring, pre configured system, anaesthesia machine, defibrillators, operating lights, surgery instrument, biosensors, LMA, suction pump), Cardiologist/Physician’s Office (echocardiography, resting ACG system, cardiology information system, stress test system), Cath Lab (haemodynamic/EP monitoring system, X-Ray Systems) and Obstetrics/Gynaecology (fetal/maternal monitoring, ultrasonography). Currently, P.T. ASM is an authorized distributor of various medical equipments such as SIEMENS, WELCH ALLYN, METRO, BIO MED, DELMAR REYNOLD, MIDRAY, MEDSYS, INVACARE and ELECTROMEDICARE brands. The whole products import from Germany, the USA and other countries. The above merchandising goods are supplied to various private and state-owned hospitals in Jakarta and its surroundings. P.T. ASM also distributes the above products to clinics and public health center. P.T. ASM is still classified as a medium-size company in the above business. Its business operation has been growing and developing well within the last three years.
Generally, demand for laboratory and medical equipment and various pharmaceutical products had been growing in the last five years up to the end 2007 as pictured in sales value of national pharmaceutical products, import value and export value issued by the Food and Drug Controlling Board (BPOM). The national pharmaceutical sales, export and import value of products are estimated to be rising by 6% to 8% in the next year. The competition is very tight on account many similar companies operating in the country.
The business position of P.T. ASM is a sufficiently fairly good because the company has captive market namely the state-owned hospital and private hospital in the country. According the BPOM that national pharmaceutical sales as shown are as the following table.
National Market Trend
of Drugs, 2001-2010 (Billion Rupiah)
|
Year |
Total Market |
Ethical Drugs |
Generic Drugs |
|
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 |
12.850 15.483 17.458 20.872 23.629 23.173 25.600 29.981 33.965 37.531 |
7.891 9.618 10.829 12.706 14.675 13.834 13.959 16.969 19.225 21,142 |
1.547 1.694 1.819 2.136 2.529 2.390 2.295 3,213 3.420 3.610 |
Source: Food and Drug Controlling Board
(BPOM)
Until this time P.T. ASM has not been registered with Indonesian Stock Exchange, so that they shall not obliged to announce their financial statement. The management of P.T. ASM is very reclusive towards outsiders and rejected to disclose its financial condition. We observed that total sales turnover of the company in 2009 amounted to Rp. 37.8 billion rose to Rp. 38.5 billion in 2010 increased to Rp. 41.0 billion in 2011 and projected to go on rising by at least 5% in 2012. The operation in 2011 yielded an estimated net profit of at least Rp. 2.8 billion and the company has an estimated total net worth of at least Rp. 13.0 billion. So far, we did not heard that the company having been black listed by the Central Bank (Bank Indonesia). The company usually pays its debts punctually to suppliers.
The management of P.T. ASM is led by Mr. Hudiono Prasetyo
(66) a businessman and professional manager with experience in trading, import
and distribution of medical equipment and hospital engineering. Daily operation
he is assisted by his son Mr. Marco Dewanto Prasetya (26) as Director. The
company's management is handled by professional staff in the above business.
They have wide relations with private businessmen within and outside the
country. So far, we did not hear that the management
of the company being filed to the district court for detrimental cases or
involved in any business malpractices. The company’s litigation record
is clean and it has not registered with the black list of Bank of Indonesia.
P.T. AIRINDO SENTRA MEDIKA is sufficiently fairly good for business
transaction.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.50.57 |
|
UK Pound |
1 |
Rs.79.57 |
|
Euro |
1 |
Rs.66.50 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.